Tg Therapeutics (TGTX) Return on Sales (2016 - 2025)
Historic Return on Sales for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to 2.42%.
- Tg Therapeutics' Return on Sales rose 23700.0% to 2.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.84%, marking a year-over-year increase of 9000.0%. This contributed to the annual value of 0.07% for FY2024, which is 200.0% up from last year.
- Per Tg Therapeutics' latest filing, its Return on Sales stood at 2.42% for Q3 2025, which was up 23700.0% from 0.2% recorded in Q2 2025.
- Tg Therapeutics' 5-year Return on Sales high stood at 2.42% for Q3 2025, and its period low was 1005.01% during Q4 2022.
- For the 5-year period, Tg Therapeutics' Return on Sales averaged around 92.29%, with its median value being 2.96% (2023).
- Its Return on Sales has fluctuated over the past 5 years, first soared by 22772000bps in 2021, then tumbled by -9645000bps in 2022.
- Over the past 5 years, Tg Therapeutics' Return on Sales (Quarter) stood at 40.51% in 2021, then tumbled by -2381bps to 1005.01% in 2022, then surged by 100bps to 0.33% in 2023, then soared by 166bps to 0.22% in 2024, then skyrocketed by 1020bps to 2.42% in 2025.
- Its last three reported values are 2.42% in Q3 2025, 0.2% for Q2 2025, and 0.04% during Q1 2025.